CLC Bio Posts 30 Percent Rise in Software Sales in 2012 | GenomeWeb

CLC Bio said this week that it saw a 30 percent rise in software sales in 2012, along with similar growth in its employee headcount.

The privately held firm, based in Aarhus, Denmark, said that it added more than 500 new customers last year.

The company now has more than 2,000 customers and more than 100 employees, CLC Bio CEO Thomas Knudsen said in statement. He said that the company is profitable and has a positive cashflow, which it will use to support further growth in the years to come.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.